{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T14:48:12Z","timestamp":1784126892701,"version":"3.55.0"},"reference-count":55,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5,1]]},"DOI":"10.1210\/en.2018-00208","type":"journal-article","created":{"date-parts":[[2018,3,28]],"date-time":"2018-03-28T20:22:19Z","timestamp":1522268539000},"page":"1966-1970","source":"Crossref","is-referenced-by-count":9,"title":["Parsing the Potential Neuroendocrine Actions of FGF21 in Primates"],"prefix":"10.1210","volume":"159","author":[{"given":"Matthew P","family":"Gillum","sequence":"first","affiliation":[{"name":"Novo Nordisk Foundation Center for Basic Metabolic Research, University of Copenhagen, Faculty of Health and Medical Sciences, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,3,28]]},"reference":[{"issue":"1","key":"2019041122115728300_B1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-4781(00)00067-1","article-title":"Identification of a novel FGF, FGF-21, preferentially expressed in the liver","volume":"1492","author":"Nishimura","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"2019041122115728300_B2","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest"},{"issue":"1","key":"2019041122115728300_B3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev-physiol-021115-105339","article-title":"Understanding the physiology of FGF21","volume":"78","author":"Fisher","year":"2016","journal-title":"Annu Rev Physiol"},{"issue":"3","key":"2019041122115728300_B4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/joim.12580","article-title":"Fibroblast growth factor 21 night watch: advances and uncertainties in the field","volume":"281","author":"Kharitonenkov","year":"2017","journal-title":"J Intern Med"},{"issue":"3","key":"2019041122115728300_B5","doi-asserted-by":"crossref","first-page":"E292","DOI":"10.1152\/ajpendo.00101.2017","article-title":"Fibroblast growth factor 21: a regulator of metabolic disease and health span","volume":"313","author":"Xie","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"2019041122115728300_B6","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1172\/JCI83349","article-title":"FGF21 and the late adaptive response to starvation in humans","volume":"125","author":"Fazeli","year":"2015","journal-title":"J Clin Invest"},{"issue":"2","key":"2019041122115728300_B7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","article-title":"The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man","volume":"8","author":"G\u00e4lman","year":"2008","journal-title":"Cell Metab"},{"issue":"8","key":"2019041122115728300_B8","doi-asserted-by":"crossref","first-page":"e22976","DOI":"10.1371\/journal.pone.0022976","article-title":"Paradoxical regulation of human FGF21 by both fasting and feeding signals: is FGF21 a nutritional adaptation factor","volume":"6","author":"Uebanso","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"2019041122115728300_B9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/EJE-12-0039","article-title":"Impact of short-term high-fat feeding and insulin-stimulated FGF21 levels in subjects with low birth weight and controls","volume":"167","author":"Vienberg","year":"2012","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2019041122115728300_B10","doi-asserted-by":"crossref","first-page":"E1224","DOI":"10.1210\/jc.2012-1132","article-title":"Dynamic change of serum FGF21 levels in response to glucose challenge in human","volume":"97","author":"Lin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2019041122115728300_B11","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"issue":"3","key":"2019041122115728300_B12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1365-2265.2008.03502.x","article-title":"Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity","volume":"71","author":"Mraz","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2019041122115728300_B13","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1053\/j.gastro.2010.04.054","article-title":"Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease","volume":"139","author":"Dushay","year":"2010","journal-title":"Gastroenterology"},{"issue":"11","key":"2019041122115728300_B14","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.molmet.2017.08.004","article-title":"Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury","volume":"6","author":"Desai","year":"2017","journal-title":"Mol Metab"},{"key":"2019041122115728300_B15","doi-asserted-by":"crossref","unstructured":"Soeberg\n              S\n            , AndersenES, DalgaardNB, JarlheltI, HansenNL, HoffmannN, VilsboellT, ChencharA, JensenM, GrevengoedTJ, TrammellSAJ, KnopFK, GillumMP. FGF21, a liver hormone that inhibits alcohol intake in mice, increases in human circulation after acute alcohol ingestion and sustained binge drinking at Oktoberfest [published online ahead of print February 13, 2018]. bioRxiv. doi: https:\/\/doi.org\/10.1101\/264234.","DOI":"10.1101\/264234"},{"issue":"50","key":"2019041122115728300_B16","doi-asserted-by":"crossref","first-page":"14372","DOI":"10.1073\/pnas.1611243113","article-title":"KLB is associated with alcohol drinking, and its gene product \u03b2-Klotho is necessary for FGF21 regulation of alcohol preference","volume":"113","author":"Schumann","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2019041122115728300_B17","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/mp.2017.153","article-title":"Genome-wide association study of alcohol consumption and genetic overlap with other health-related traits in UK Biobank (N=112\u2009117)","volume":"22","author":"Clarke","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"5","key":"2019041122115728300_B18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.cmet.2017.04.009","article-title":"FGF21 is a sugar-induced hormone associated with sweet intake and preference in humans","volume":"25","author":"S\u00f8berg","year":"2017","journal-title":"Cell Metab"},{"key":"2019041122115728300_B19","doi-asserted-by":"crossref","unstructured":"Frayling\n              TM\n            , BeaumontR, JonesSE, YaghootkarH, TukeMA, RuthKS, CasanovaF, WestB, LockeJ, SharpS, JieY, ThompsonWD, HarrisonJW, LindgrenCM, GrarupN, MurrayA, FreathyRM, WeedonMN, TyrrellJ, WoodAR. A common allele in FGF21 associated with preference for sugar consumption lowers body fat in the lower body and increases blood pressure [published online ahead of print November 6, 2016]. bioRxiv. doi: https:\/\/doi.org\/10.1101\/214700","DOI":"10.1101\/214700"},{"issue":"6","key":"2019041122115728300_B20","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2337\/db16-1384","article-title":"An exome-chip association analysis in Chinese subjects reveals a functional missense variant ofGCKR that regulates FGF21 levels","volume":"66","author":"Cheung","year":"2017","journal-title":"Diabetes"},{"issue":"1","key":"2019041122115728300_B21","doi-asserted-by":"crossref","first-page":"31026","DOI":"10.1038\/srep31026","article-title":"Fibroblast growth factor 21 deficiency exacerbates chronic alcohol-induced hepatic steatosis and injury","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"2019041122115728300_B22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cmet.2015.12.008","article-title":"FGF21 regulates sweet and alcohol preference","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab"},{"issue":"9","key":"2019041122115728300_B23","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/hmg\/ddt032","article-title":"Novel locus including FGF21 is associated with dietary macronutrient intake","volume":"22","author":"Chu","year":"2013","journal-title":"Hum Mol Genet"},{"issue":"6","key":"2019041122115728300_B24","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3945\/ajcn.112.052183","article-title":"Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake","volume":"97","author":"Tanaka","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"2019041122115728300_B25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cmet.2015.12.003","article-title":"FGF21 mediates endocrine control of simple sugar intake and sweet taste preference by the liver","volume":"23","author":"von Holstein-Rathlou","year":"2016","journal-title":"Cell Metab"},{"issue":"1","key":"2019041122115728300_B26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmet.2014.09.008","article-title":"Fructose ingestion acutely stimulates circulating FGF21 levels in humans","volume":"4","author":"Dushay","year":"2014","journal-title":"Mol Metab"},{"issue":"1","key":"2019041122115728300_B27","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.molmet.2016.11.001","article-title":"Circulating FGF21 in humans is potently induced by short term overfeeding of carbohydrates","volume":"6","author":"Lundsgaard","year":"2016","journal-title":"Mol Metab"},{"issue":"1","key":"2019041122115728300_B28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.molmet.2016.11.008","article-title":"A critical role for ChREBP-mediated FGF21 secretion in hepatic fructose metabolism","volume":"6","author":"Fisher","year":"2016","journal-title":"Mol Metab"},{"issue":"2","key":"2019041122115728300_B29","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.celrep.2017.09.065","article-title":"A specific ChREBP and PPAR\u03b1 cross-talk is required for the glucose-mediated FGF21 response","volume":"21","author":"Iroz","year":"2017","journal-title":"Cell Rep"},{"issue":"2","key":"2019041122115728300_B30","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.cmet.2017.07.004","article-title":"Sweet sixteenth for ChREBP: established roles and future goals","volume":"26","author":"Abdul-Wahed","year":"2017","journal-title":"Cell Metab"},{"issue":"3","key":"2019041122115728300_B31","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cmet.2016.02.001","article-title":"A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects","volume":"23","author":"Talukdar","year":"2016","journal-title":"Cell Metab"},{"issue":"4","key":"2019041122115728300_B32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10928-016-9481-1","article-title":"PF-05231023, a long-acting FGF21 analogue, decreases body weight by reduction of food intake in non-human primates","volume":"43","author":"Thompson","year":"2016","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"3","key":"2019041122115728300_B33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab"},{"issue":"3","key":"2019041122115728300_B34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2016.01.006","article-title":"FGF21 lowers plasma triglycerides by accelerating lipoprotein catabolism in white and brown adipose tissues","volume":"23","author":"Schlein","year":"2016","journal-title":"Cell Metab"},{"issue":"5","key":"2019041122115728300_B35","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.cmet.2013.03.019","article-title":"An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice","volume":"17","author":"Holland","year":"2013","journal-title":"Cell Metab"},{"issue":"26","key":"2019041122115728300_B36","doi-asserted-by":"crossref","first-page":"10853","DOI":"10.1073\/pnas.0904187106","article-title":"FGF21 induces PGC-1\u03b1 and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response","volume":"106","author":"Potthoff","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019041122115728300_B37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab"},{"issue":"3","key":"2019041122115728300_B38","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3945\/ajcn.112.044545","article-title":"Common genetic loci influencing plasma homocysteine concentrations and their effect on risk of coronary artery disease","volume":"98","author":"van Meurs","year":"2013","journal-title":"Am J Clin Nutr"},{"issue":"7","key":"2019041122115728300_B39","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1161\/STROKEAHA.114.005208","article-title":"Effect of genetic variants associated with plasma homocysteine levels on stroke risk","volume":"45","author":"Cotlarciuc","year":"2014","journal-title":"Stroke"},{"issue":"12","key":"2019041122115728300_B40","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/dom.13023","article-title":"Once-weekly administration of a long-acting fibroblast growth factor 21 analogue modulates lipids, bone turnover markers, blood pressure and body weight differently in obese people with hypertriglyceridaemia and in non-human primates","volume":"19","author":"Kim","year":"2017","journal-title":"Diabetes Obes Metab"},{"issue":"5","key":"2019041122115728300_B41","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.2337\/db12-1116","article-title":"Fibroblast growth factor 21 mediates specific glucagon actions","volume":"62","author":"Habegger","year":"2013","journal-title":"Diabetes"},{"issue":"8","key":"2019041122115728300_B42","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1073\/pnas.1200797109","article-title":"Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor \u03b3","volume":"109","author":"Wei","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019041122115728300_B43","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1002\/jbmr.2936","article-title":"FGF21 is not a major mediator for bone homeostasis or metabolic actions of PPAR\u03b1 and PPAR\u03b3 agonists","volume":"32","author":"Li","year":"2017","journal-title":"J Bone Miner Res"},{"issue":"22","key":"2019041122115728300_B44","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1212\/WNL.0000000000003374","article-title":"FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders","volume":"87","author":"Lehtonen","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"2019041122115728300_B45","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3390\/jcm6080080","article-title":"Use of FGF-21 as a biomarker of mitochondrial disease in clinical practice","volume":"6","author":"Morovat","year":"2017","journal-title":"J Clin Med"},{"issue":"8","key":"2019041122115728300_B46","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.molmet.2015.06.001","article-title":"Glucagon-to-insulin ratio is pivotal for splanchnic regulation of FGF-21 in humans","volume":"4","author":"Hansen","year":"2015","journal-title":"Mol Metab"},{"issue":"9","key":"2019041122115728300_B47","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1172\/JCI74915","article-title":"FGF21 is an endocrine signal of protein restriction","volume":"124","author":"Laeger","year":"2014","journal-title":"J Clin Invest"},{"issue":"4","key":"2019041122115728300_B48","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cmet.2016.09.001","article-title":"Defining the nutritional and metabolic context of FGF21\u00a0using the geometric framework","volume":"24","author":"Solon-Biet","year":"2016","journal-title":"Cell Metab"},{"key":"2019041122115728300_B49","doi-asserted-by":"crossref","first-page":"807874","DOI":"10.1155\/2014\/807874","article-title":"ATF4- and CHOP-dependent induction of FGF21 through endoplasmic reticulum stress","volume":"2014","author":"Wan","year":"2014","journal-title":"BioMed Res Int"},{"issue":"1","key":"2019041122115728300_B50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.celrep.2016.05.062","article-title":"Hepatic fatty acid oxidation restrains systemic catabolism during starvation","volume":"16","author":"Lee","year":"2016","journal-title":"Cell Reports"},{"issue":"6","key":"2019041122115728300_B51","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.cmet.2017.10.017","article-title":"GDF15: from biomarker to allostatic hormone","volume":"26","author":"O\u2019Rahilly","year":"2017","journal-title":"Cell Metab"},{"issue":"5","key":"2019041122115728300_B52","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1042\/BJ20151085","article-title":"Circulating FGF21 proteolytic processing mediated by fibroblast activation protein","volume":"473","author":"Zhen","year":"2016","journal-title":"Biochem J"},{"issue":"3","key":"2019041122115728300_B53","doi-asserted-by":"crossref","first-page":"e0151269","DOI":"10.1371\/journal.pone.0151269","article-title":"Human FGF-21 Is a Substrate of Fibroblast Activation Protein","volume":"11","author":"Coppage","year":"2016","journal-title":"PLoS One"},{"issue":"11","key":"2019041122115728300_B54","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.1074\/jbc.M115.710582","article-title":"Fibroblast activation protein cleaves and inactivates fibroblast growth factor 21","volume":"291","author":"Dunshee","year":"2016","journal-title":"J Biol Chem"},{"issue":"10","key":"2019041122115728300_B55","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.molmet.2016.07.003","article-title":"Fibroblast activation protein (FAP) as a novel metabolic target","volume":"5","author":"S\u00e1nchez-Garrido","year":"2016","journal-title":"Mol Metab"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/159\/5\/1966\/24570518\/en.2018-00208.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T15:46:09Z","timestamp":1555083969000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/159\/5\/1966\/4955652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,28]]},"references-count":55,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,3,28]]},"published-print":{"date-parts":[[2018,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2018-00208","relation":{},"ISSN":["1945-7170"],"issn-type":[{"value":"1945-7170","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,5]]},"published":{"date-parts":[[2018,3,28]]}}}